Log in to save to my catalogue

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of...

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3671272

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

About this item

Full title

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

Publisher

Kidlington: Elsevier Ltd

Journal title

The Lancet (British edition), 2013-05, Vol.381 (9880), p.1827-1834

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Tamoxifen and raloxifene reduce the risk of breast cancer in women at elevated risk of disease, but the duration of the effect is unknown. We assessed the effectiveness of selective oestrogen receptor modulators (SERMs) on breast cancer incidence. Methods We did a meta-analysis with individual participant data from nine preventio...

Alternative Titles

Full title

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3671272

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3671272

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(13)60140-3

How to access this item